Latest Breaking News On - Universite de sherbrooke - Page 10 : comparemela.com
Key fixes needed to Canada s early-warning system before next pandemic: review
ctvnews.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ctvnews.ca Daily Mail and Mail on Sunday newspapers.
High-throughput RNA analysis platform unveiled in Quebec - Lab Canada
labcanada.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from labcanada.com Daily Mail and Mail on Sunday newspapers.
New super-resolution technique allows for more detailed brain imaging
eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.
VANCOUVER Researchers say a new drug tested at the University of British Columbia is highly effective against multiple COVID-19 variants. They say the experimental drug called N-0385, developed at Universite de Sherbrooke in Quebec, blocks the virus that causes COVID-19 from entering human cells through its preferred entry point. The experimental drug impedes cellular entry of the virus, says Dr. Richard Leduc, project lead at Sherbrooke. “It’s not a treatment, it’s a protector against the virus, Leduc said, which is why they believe it will work against all variants. N-0385 doesn’t combat a specific strain of COVID-19. It s designed to block viruses of all kinds from entering the human cell in the first place.
Jacob Serebrin
A woman receives her COVID-19 vaccine at a vaccination clinic in Montreal s Olympic Stadium on Tuesday, Feb. 23, 2021. THE CANADIAN PRESS/Paul Chiasson February 25, 2021 - 1:00 AM
MONTREAL - Lucie Tremblay wants her colleagues in Quebec s health-care sector to get vaccinated against COVID-19.
The head of nursing at the regional health board for west-central Montreal has taken a leading role in the board s efforts to reduce vaccine hesitancy among its employees.
Tremblay said some of her colleagues are still reluctant to get an injection, but they are noticeably fewer than a few months ago. âThere s a lot of people that are very enthusiastic about getting the vaccine, but they re not yet on the priority list,â she said in a recent interview.